Showing 1 - 10 of 14
Innovation policy involves trading off monopoly output and pricing in the short run in exchange for incentives for …
Persistent link: https://www.econbiz.de/10012481677
We explore the use of patent citations to measure the "basicness" and appropriability of inventions. We propose that the basicness of research underlying an invention can be characterized by the nature of the previous patents cited by an invention; that the basicness of research outcomes relates...
Persistent link: https://www.econbiz.de/10012474824
Precision medicines - therapies that rely on the use of genetic, epigenetic, and protein biomarkers - create a better match between patients with specific disease subtypes and medications that are more effective for those patients. This heterogeneity in response has implications for the decision...
Persistent link: https://www.econbiz.de/10012453687
Persistent link: https://www.econbiz.de/10001220135
the israeli economy in the nineties and beyond. In this paper we present a close-up portrait of innovation in Israel for …
Persistent link: https://www.econbiz.de/10012471778
This paper explores the economic incentives for medical procedure innovation. Using a proprietary dataset on billing … code applications for emerging medical procedures, we highlight two mechanisms that could hinder innovation. First, the … administrative hurdle of securing permanent, reimbursable billing codes substantially delays innovation diffusion. We find that …
Persistent link: https://www.econbiz.de/10012660115
applied to the case of Computed Tomography (CT) Scanners, a revolutionary innovation in medical technology. The econometric … from innovation is used primarily to compute a social rate of return to R&D, to explore the interrelation between … innovation and diffusion, and to trace the time profile of benefits and costs, the latter suggesting the possible occurance of …
Persistent link: https://www.econbiz.de/10012477355
Pharmaceutical innovation policy involves managing a tradeoff between high prices for new products in the short … pharmaceuticals, suggesting low(er) price markets may have different dynamics with respect to innovation policy …
Persistent link: https://www.econbiz.de/10012533304
from pharmaceutical innovation. Extending previous studies of the welfare benefits from innovation (Trajtenberg, 1990 …
Persistent link: https://www.econbiz.de/10012471921
segmentation) shaped the underlying incen- tives for innovation in the PC industry during the mid to late 1980s …
Persistent link: https://www.econbiz.de/10012473112